Nationwide Fund Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-24,500	Closed	-$3.58M	–	1051
2017 Q3	$3.58M	Buy	24,500 +3,500	+17%	+$529K	0.01%	1171
2017 Q2	$3.27M	Buy	21,000 +9,750	+87%	+$1.49M	0.01%	1215
2017 Q1	$1.63M	Sell	11,250 -11,250	-50%	-$1.47M	0.01%	1500
2016 Q4	$2.45M	Sell	22,500 -65,720	-74%	-$7.32M	0.01%	1320
2016 Q3	$10.7M	Sell	88,220 -58,810	-40%	-$7.93M	0.04%	579
2016 Q2	$20.8M	Buy	147,030 +126,432	+614%	+$18.6M	0.09%	261
2016 Q1	$2.69M	Buy	20,598 +4,266	+26%	+$531K	0.01%	1213
2015 Q4	$2.3M	Sell	16,332 -8,126	-33%	-$1.13M	0.01%	1304
2015 Q3	$3.25M	Sell	24,458 -24,481	-50%	-$4.22M	0.01%	1131
2015 Q2	$8.62M	Sell	48,939 -31,960	-40%	-$5.74M	0.04%	657
2015 Q1	$14M	Buy	80,899 +22,942	+40%	+$3.94M	0.06%	437
2014 Q4	$9.49M	Buy	57,957 +2,557	+5%	+$424K	0.04%	580
2014 Q3	$8.89M	Buy	55,400 +5,900	+12%	+$907K	0.04%	621
2014 Q2	$7.28M	Sell	49,500 -33,416	-40%	-$4.63M	0.03%	760
2014 Q1	$11.5M	Buy	82,916 +48,690	+142%	+$7.33M	0.05%	442
2013 Q4	$4.33M	Sell	34,226 -16,310	-32%	-$1.69M	0.02%	1030
2013 Q3	$4.65M	Buy	50,536 +10,920	+28%	+$881K	0.02%	948
2013 Q2	$2.72M	Buy	+39,616	New	+$2.42M	0.01%	1127